From: An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromes
A. Screening cohort analyzed in cytokine microarray experiment | |||||
---|---|---|---|---|---|
PSP/CBS | MSA | PD | CTRL | p-value | |
Number | 10 | 10 | 20 | 30 | |
Female, n(%) | 6(60) | 6(60) | 12(60) | 18(60) | nsb |
Age, ya | 68(54–75) | 66(54–75) | 67(52–81) | 65(56–80) | nsc |
Duration, ya | 4(1–8) | 5(1–9) | 6(1–37) | nsc | |
Hoehn&Yahra | 3(2–5) | 4(2–5) | 2(1–4) | <0.001c | |
Dementia, n(%) | 3(30) | 2(20) | 2(10) | nsb | |
Treatment, n(%) | 9(90) | 5(50) | 18(90) | ns | |
PSP/CBS | MSA | PD | CTRL | p-value | |
Number | 28 | 21 | 97 | 69 | |
Female, n(%) | 14(50) | 14(67) | 32(33) | 29(42) | 0.03b |
Age, ya | 74(57–84) | 63(46–78) | 66(41–85) | 63(42–93) | <0.001c |
Duration, ya | 3(1–11) | 3(1–6) | 4(0–27) | nsc | |
Hoehn&Yahra | 4(2–5) | 4(0–5) | 2(0–5) | <0.001c | |
Dementia, n(%) | 14(52) | 0(0) | 10(11) | <0.001b | |
Treatment, n(%) | 19(68) | 15(71) | 63(65) | nsb |